Apyx Medical Corp (APYX) Stock Price, Quote & News

Latest News on APYX

Jan 6, 2025, 8:00 AM EST - 11 days ago

Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™

Nov 12, 2024, 4:05 PM EST - 2 months ago

Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference

Nov 8, 2024, 1:39 PM EST - 2 months ago

Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 7:05 AM EST - 2 months ago

Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering

Nov 8, 2024, 7:00 AM EST - 2 months ago

Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook

Oct 25, 2024, 8:00 AM EDT - 3 months ago

Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024

Aug 13, 2024, 8:10 AM EDT - 5 months ago

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Aug 11, 2024, 6:39 AM EDT - 5 months ago

Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:10 PM EDT - 5 months ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures

Aug 8, 2024, 4:05 PM EDT - 5 months ago

Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook

Jul 25, 2024, 7:30 AM EDT - 6 months ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 26, 2024, 7:30 AM EDT - 7 months ago

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health

May 11, 2024, 6:33 PM EDT - 8 months ago

Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:05 AM EDT - 9 months ago

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook

May 9, 2024, 7:00 AM EDT - 9 months ago

Apyx Medical Corporation Announces Board Leadership Transition

Apr 25, 2024, 7:30 AM EDT - 9 months ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apr 11, 2024, 7:30 AM EDT - 10 months ago

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit

Mar 21, 2024, 10:12 AM EDT - 10 months ago

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 7:00 AM EDT - 10 months ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Mar 4, 2024, 7:30 AM EST - 11 months ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Feb 21, 2024, 7:30 AM EST - 11 months ago

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Jan 22, 2024, 7:30 AM EST - 1 year ago

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

Jan 8, 2024, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results

Nov 28, 2023, 8:30 AM EST - 1 year ago

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer

Nov 9, 2023, 11:30 AM EST - 1 year ago

Apyx Medical Corporation (APYX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:01 AM EST - 1 year ago

Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Nov 9, 2023, 7:00 AM EST - 1 year ago

Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

Nov 7, 2023, 7:30 AM EST - 1 year ago

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Oct 2, 2023, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Aug 12, 2023, 12:09 PM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook

Jun 29, 2023, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023

Jun 14, 2023, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece

May 11, 2023, 10:21 AM EDT - 1 year ago

Apyx Medical Corporation (APYX) Q1 2023 Earnings Call Transcript

May 11, 2023, 7:00 AM EDT - 1 year ago

Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook

May 2, 2023, 7:30 AM EDT - 1 year ago

RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

Apr 28, 2023, 7:30 AM EDT - 1 year ago

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Apr 5, 2023, 4:05 PM EDT - 1 year ago

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Mar 27, 2023, 6:55 AM EDT - 1 year ago

Renuvion Wins ADDY® Award for #ThisIsMe Campaign

Mar 16, 2023, 11:30 AM EDT - 2 years ago

Apyx Medical Corporation (APYX) Q4 2022 Earnings Call Transcript

Mar 16, 2023, 7:00 AM EDT - 2 years ago

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Feb 27, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed

Feb 21, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial

Feb 16, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023

Feb 9, 2023, 7:30 AM EST - 2 years ago

RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13

Feb 1, 2023, 7:30 AM EST - 2 years ago

Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

Jan 25, 2023, 7:30 AM EST - 2 years ago

APYX MEDICAL CORPORATION LAUNCHES NEW 'APYX ONE CONSOLE' FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES

Jan 10, 2023, 7:00 AM EST - 2 years ago

Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

Jan 3, 2023, 7:30 AM EST - 2 years ago

APYX® MEDICAL CORPORATION EMBARKS ON INAUGURAL BRAND CAMPAIGN FOR RENUVION®

Nov 22, 2022, 4:05 PM EST - 2 years ago

Market Cap	53.45M
Revenue (ttm)	52.35M
Net Income (ttm)	-18.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-35.74%
Debt to Equity Ratio	3.02

Volume	16,500
Avg Vol	66,384
Day's Range	N/A - N/A
Shares Out	37.64M
Stochastic %K	2%
Beta	1.26
Analysts	Sell
Price Target	$2.00